TRT 'life changing' claims: what the evidence actually supports

What did @realalejandroreyes actually say?

The short version: he went from 200mg to 300mg of testosterone weekly, added 25mg of anavar (oxandrolone), and says his physique "drastically changed" in positive ways. He ran this stack for eight to ten weeks and reported bigger pumps, more vascularity, and a leaner, fuller look. He also credited 200mg TRT with making more money in business. Those are two very different types of claims, and they deserve to be treated differently.

To his credit, he frames this explicitly as personal experience. He says, "that's just my personal experience" and does not tell viewers to copy his protocol. That disclaimer matters, even if it doesn't make the underlying information safe for general audiences.

Does the science back this up?

Some of it, yes. But the framing glosses over real risks, and the doses he describes are not typical therapeutic TRT. The physique changes he describes are real and documented, but they come with tradeoffs he never mentions.

On testosterone dose-response: a landmark Bhasin et al. (2001, NEJM) study demonstrated that higher testosterone doses produce greater increases in muscle mass and strength in a dose-dependent manner. So the idea that going from 200mg to 300mg weekly improved his physique is biologically plausible, not fiction.

On anavar specifically: oxandrolone is an anabolic steroid with a relatively favorable androgenic profile. Studies like Orr and Singh (2004, Drugs and Aging) confirm it increases lean mass and reduces body fat. The "drier, leaner" look he describes is consistent with oxandrolone's low aromatization rate. That part checks out mechanically.

What the science also shows, and what he skips entirely: supraphysiological testosterone suppresses endogenous production, raises hematocrit, and at 300mg weekly is well above any standard therapeutic dose range used in clinical hypogonadism treatment (typically 100-200mg weekly per Endocrine Society guidelines, Bhasin et al., 2018). That omission is a problem.

What did they get wrong (or right)?

He got the physique mechanism roughly right. Higher testosterone plus oxandrolone will produce the effects he described in many users. That is not controversial among endocrinologists or sports medicine researchers.

What he got wrong, or at least dangerously incomplete: treating 300mg weekly as a TRT dose. Standard TRT targets physiological testosterone levels, roughly 400-700 ng/dL in most clinical protocols. At 300mg weekly, most men will run testosterone levels far above that range. That is not replacement. That is supraphysiological use, which carries meaningfully different risk profiles including elevated cardiovascular risk, polycythemia, and lipid dysregulation (Corona et al., 2017, European Journal of Endocrinology).

The business success correlation is the weakest claim in the video. Attributing income growth to a testosterone dose is unverifiable and potentially misleading for viewers who are already motivated to start or escalate hormone use for non-medical reasons. Testosterone does affect motivation and cognition in hypogonadal men, but the effect size in business outcomes is not something any study has credibly measured.

What should you actually know?

If you are considering TRT, the dose and the outcome this creator describes are not what regulated TRT programs are designed to deliver. Legitimate TRT is about restoring physiological hormone levels, not optimizing physique or business performance at supraphysiological concentrations.

Anavar is a controlled Schedule III substance in the United States. It is not available through standard TRT pathways and is not approved for use in otherwise healthy men seeking body composition changes. Stacking it with high-dose testosterone without medical supervision and regular bloodwork is genuinely risky, not just a disclaimer formality.

The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, JCEM) are clear: TRT is indicated for men with symptomatic hypogonadism confirmed by laboratory testing. The goal is normalization of testosterone levels, not maximization. Anyone describing 300mg weekly as their TRT dose is either using the term loosely or is not on a medically supervised protocol calibrated to that standard.

If you are working with a regulated telehealth provider, your provider will monitor your labs, keep your dose within therapeutic ranges, and will not stack anabolic steroids onto your protocol without a legitimate clinical rationale. That is the difference between hormone optimization and performance-enhancing drug use.